Search
Returning search results with filters:
Remove filter for
Audience: Industry
Remove filter for
Recall class: Type I
Clear all
Type
Audience
Category
Issue
Last updated
Recall class
Please note: using the search filters may not provide accurate search results for records prior to November 2021. When searching for older records, please ensure that you use the include archive checkbox.
Displaying 1 - 15 of 29 items.
Affected lot may contain the presence of particles.
RecallHealth product recall | 2023-05-15
Auto-injectors may be malfunctioning in affected lots.
RecallHealth product recall | 2023-05-08
Solution bags may be leaking in affected lots.
RecallHealth product recall | 2023-05-05
Vials may be cracked in affected lots.
RecallHealth product recall | 2023-03-03
Affected lot exceeds concentration limit for N-nitrosodimethylamine (NDMA) at the 48-month stability testing timepoint.
RecallHealth product recall | 2023-02-07
Presence of particulate matter in affected lot.
RecallHealth product recall | 2023-01-18
Affected lot may result in a false negative for skin test (peanut allergy).
RecallHealth product recall | 2022-12-14
Affected lot contains active ingredient (Cholecalciferol) levels outside of the labelled claim.
RecallHealth product recall | 2022-12-08
Affected lot may result in a false negative for skin test (peanut allergy)
RecallHealth product recall | 2022-11-15
Intravenous bag may be leaking in affected lots.
RecallHealth product recall | 2022-11-03
Affected lot is labelled with the incorrect strength and ingredient
RecallHealth product recall | 2022-10-24
Affected lot may contain particulate matter
RecallHealth product recall | 2022-08-30
Jamp Pharma Corporation is recalling one lot (D10776B) of Jamp-Atorvastatin Calcium after one bottle labelled to contain 10 mg tablets of Jamp-Atorvastatin Calcium was found to contain 40 mg tablets of Jamp-Atorvastatin Calcium.
Pharmacists may not…
RecallHealth product recall | 2022-08-29
Pharmascience Inc. is recalling one lot of pms-Hydromorphone, 2 mg tablets, (lot 639268) as the bottles may contain hydromorphone tablets of a different strength (8 mg), meaning they contain higher amounts of hydromorphone. Products from the affected lot…
RecallHealth product recall | 2022-08-22
Taro Pharmaceuticals Inc. is recalling all lots of Taro-Zoledronic acid injection 5mg/100mL (DIN 02415100) because they may contain particulate matter.
Zoledronic acid is a prescription drug used to treat and prevent osteoporosis and to treat Paget's…
RecallHealth product recall | 2022-08-10